Global Medical/Diagnostic Imaging Market - Forecasts from 2025 to 2030

Description

The Medical/Diagnostic Imaging Market is expected to grow from US$45.240 billion in 2025 to US$57.831 billion in 2030, at a CAGR of 5.03%.

Medical imaging consists of different imaging modalities and processes to image the human body for diagnostic and treatment purposes. A variety of machines and techniques are used to create the pictures of the structures and activities inside your body. The type of imaging techniques used depends on the symptoms and the part of the body to be examined.

The growth in the medical/diagnostic imaging market may be attributed to the continuous technological advancements in diagnostic imaging modalities. Rising prevalence of chronic diseases such as cancer, cardiovascular, and neurological disorders requiring medical imaging for diagnosis will also have a positive impact on the market growth.

Growth in the number of diagnostic imaging centers will also boost the market for medical/diagnostic imaging during the given forecast period. However, the high cost of medical imaging systems coupled with the rising adoption of refurbished medical imaging devices may hamper the growth of the market during the given time frame.

Major industry players profiled as part of the report are Fujifilm Corporation, Canon Medical Systems Corporation, and Koninklijke Philips N.V. among others.

Medical/Diagnostic Imaging Market Segmentation:

Global Medical/Diagnostic Imaging Market By Software
Standalone Software
Integrated Software
Global Medical/Diagnostic Imaging Market By Imaging Modality
X-Ray Imaging
Magnetic Resonance Imaging (MRI)
Ultrasound Imaging
Computerised Tomography (CT) Scanning
Nuclear Imaging
Others
Global Medical/Diagnostic Imaging Market By End Users
Hospitals
Diagnostic Centers
Others

By Geography

North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others

Product Code: KSI061611922

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY SOFTWARE

5.1. Introduction
5.2. Standalone Software
5.3. Integrated Software

6. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY IMAGING MODALITY

6.1. Introduction
6.2. X-Ray Imaging
6.3. Magnetic Resonance Imaging (MRI)
6.4. Ultraound Imaging
6.5. Computerised Tomography (CT) Scannig
6.6. Nuclear Imaging
6.7. Others

7. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Centers
7.4. Others

8. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. General Electric Healthcare
10.2. Koninklijke Philips N.V.
10.3. Siemens AG
10.4. Shimadzu Corporation
10.5. Canon Medical Systems Corporation (Canon)
10.6. Carestream Health
10.7. Esaote SpA
10.8. Samsung Healthcare (Samsung)
10.9. Fujifilm Corporation
10.10. Mindray Medical International Limited

11. APPENDIX

11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key Benefits for the Stakeholders
11.5. Research Methodology
11.6. Abbreviations